DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced the acquisition of the dialysis operations of Malaysia’s Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.
“This is an important move for DaVita in the Asia-Pacific region,” said Dennis Kogod, chief operating officer of DaVita HealthCare Partners TM. “Scaling up operations in Malaysia allows us to bring outstanding quality of care to this region.”
With the addition of CDC Group’s 18 centers, DaVita now operates a total of 21 centers in Malaysia with plans to expand in the coming years.
“We’re excited to build on the reputation of CDC Group and to welcome the teammates and patients from their 18 centers to DaVita,” said Atul Mathur, president of DaVita’s Asia-Pacific operations. “Malaysia is a key market for our growth strategy in the Asia-Pacific region where we are now serving patients in five countries.”DaVita has improved clinical outcomes 13 years in a row in the United States and has consistently demonstrated clinical results that are the best or among the best in virtually every category in the kidney care industry. These outcomes help drive lower mortality rates and fewer hospitalizations, directly supporting DaVita’s aim to improve patients’ health and quality of life. “We always have been dedicated to delivering quality care to our patients, and we constantly seek opportunities to improve the care they receive,” said Dr. Ong Kee Liang, founding nephrologist of CDC Group. “With DaVita’s impressive record of improved clinical outcomes coming to the patients in our centers, we believe it is our patients who are the true beneficiaries of this transaction.” For more information, visit DaVita.com. DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts